z-logo
open-access-imgOpen Access
Machine Learning Highlights Downtrending of COVID-19 Patients with a Distinct Laboratory Profile
Author(s) -
He S. Yang,
Yu Hou,
Hao Zhang,
Amy Chadburn,
Lars F. Westblade,
Richard Fedeli,
Peter Steel,
Sabrina RacineBrzostek,
Priya Velu,
Jorge L. Sepulveda,
Michael J. Satlin,
Melissa M. Cushing,
Rainu Kaushal,
Zhen Zhao,
Fei Wang
Publication year - 2021
Publication title -
health data science
Language(s) - English
Resource type - Journals
eISSN - 2097-1095
pISSN - 2765-8783
DOI - 10.34133/2021/7574903
Subject(s) - covid-19 , medicine , viral load , population , retrospective cohort study , emergency department , disease , virology , infectious disease (medical specialty) , virus , outbreak , environmental health , psychiatry
Background . New York City (NYC) experienced an initial surge and gradual decline in the number of SARS-CoV-2-confirmed cases in 2020. A change in the pattern of laboratory test results in COVID-19 patients over this time has not been reported or correlated with patient outcome. Methods . We performed a retrospective study of routine laboratory and SARS-CoV-2 RT-PCR test results from 5,785 patients evaluated in a NYC hospital emergency department from March to June employing machine learning analysis. Results . A COVID-19 high-risk laboratory test result profile (COVID19-HRP), consisting of 21 routine blood tests, was identified to characterize the SARS-CoV-2 patients. Approximately half of the SARS-CoV-2 positive patients had the distinct COVID19-HRP that separated them from SARS-CoV-2 negative patients. SARS-CoV-2 patients with the COVID19-HRP had higher SARS-CoV-2 viral loads, determined by cycle threshold values from the RT-PCR, and poorer clinical outcome compared to other positive patients without the COVID12-HRP. Furthermore, the percentage of SARS-CoV-2 patients with the COVID19-HRP has significantly decreased from March/April to May/June. Notably, viral load in the SARS-CoV-2 patients declined, and their laboratory profile became less distinguishable from SARS-CoV-2 negative patients in the later phase. Conclusions . Our longitudinal analysis illustrates the temporal change of laboratory test result profile in SARS-CoV-2 patients and the COVID-19 evolvement in a US epicenter. This analysis could become an important tool in COVID-19 population disease severity tracking and prediction. In addition, this analysis may play an important role in prioritizing high-risk patients, assisting in patient triaging and optimizing the usage of resources.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom